Karen L Tubridy - Net Worth and Insider Trading
Karen L Tubridy Net Worth
The estimated net worth of Karen L Tubridy is at least $112,623 dollars as of 2024-04-26. Karen L Tubridy is the SVP, Chief Development Officer of Akebia Therapeutics Inc and owns about 84,679 shares of Akebia Therapeutics Inc (AKBA) stock worth over $112,623. Details can be seen in Karen L Tubridy's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Karen L Tubridy has not made any transactions after 2020-02-28 and currently still holds the listed stock(s).
Transaction Summary of Karen L Tubridy
Karen L Tubridy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Karen L Tubridy owns 3 companies in total, including Akebia Therapeutics Inc (AKBA) , Sesen Bio Inc (SESN) , and CARISMA Therapeutics Inc (CARM) .
Click here to see the complete history of Karen L Tubridy’s form 4 insider trades.
Insider Ownership Summary of Karen L Tubridy
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AKBA | Akebia Therapeutics Inc | 2020-02-28 | SVP & Chief Development Officer |
| SESN | Sesen Bio Inc | 2014-02-05 | Chief Development Officer |
| CARM | CARISMA Therapeutics Inc | 2014-02-05 | Chief Development Officer |
Karen L Tubridy Latest Holdings Summary
Karen L Tubridy currently owns a total of 1 stock. Karen L Tubridy owns 84,679 shares of Akebia Therapeutics Inc (AKBA) as of February 28, 2020, with a value of $112,623.
Latest Holdings of Karen L Tubridy
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics Inc | 2020-02-28 | 84,679 | 1.33 | 112,623 |
Holding Weightings of Karen L Tubridy
Karen L Tubridy Form 4 Trading Tracker
According to the SEC Form 4 filings, Karen L Tubridy has made a total of 1 transactions in Akebia Therapeutics Inc (AKBA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Akebia Therapeutics Inc is the sale of 3,454 shares on February 28, 2020, which brought Karen L Tubridy around $30,050.
Insider Trading History of Karen L Tubridy
- 1
Karen L Tubridy Trading Performance
Karen L Tubridy Ownership Network
Ownership Network List of Karen L Tubridy
Ownership Network Relation of Karen L Tubridy
Karen L Tubridy Owned Company Details
What does Akebia Therapeutics Inc do?
Who are the key executives at Akebia Therapeutics Inc?
Karen L Tubridy is the SVP & Chief Development Officer of Akebia Therapeutics Inc. Other key executives at Akebia Therapeutics Inc include SVP & Chief Business Officer Michel Dahan , director & CEO & President John P. Butler , and SVP & General Counsel & Sec. Nicole R. Hadas .
Akebia Therapeutics Inc (AKBA) Insider Trades Summary
Over the past 18 months, Karen L Tubridy made no insider transaction in Akebia Therapeutics Inc (AKBA). Other recent insider transactions involving Akebia Therapeutics Inc (AKBA) include a net sale of 145,385 shares made by Michel Dahan , a net sale of 100,765 shares made by Steven Keith Burke , and a net sale of 96,282 shares made by Nicole R. Hadas .
In summary, during the past 3 months, insiders sold 132,629 shares of Akebia Therapeutics Inc (AKBA) in total and bought 0 shares, with a net sale of 132,629 shares. During the past 18 months, 635,551 shares of Akebia Therapeutics Inc (AKBA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 635,551 shares.
Akebia Therapeutics Inc (AKBA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akebia Therapeutics Inc Insider Transactions
Karen L Tubridy Mailing Address
Above is the net worth, insider trading, and ownership report for Karen L Tubridy. You might contact Karen L Tubridy via mailing address: Eleven Biotherapeutics, Inc., 215 First Street, Suite 400, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
